The Genetic Trade-Off: Youthful Growth at the Cost of Cancer

"We have effectively caught evolution in the act of making a trade-off."
— Geneticist Itamar Harel, Hebrew University of Jerusalem

Key Findings

Researchers at the Hebrew University of Jerusalem studied the vestigial-like 3 (vgll3) gene in African turquoise killifish. Using CRISPR gene editing, they modified vgll3 to disrupt its protein production.

The modified fish exhibited accelerated growth, earlier sexual maturity, and increased rates of age-related tumors, including melanoma-like cancers.

These findings support the theory of antagonistic pleiotropy, where a gene confers early-life benefits but late-life costs. In its unmodified state, vgll3 appears to function as a brake on growth and cell division.

Background

Natural variations in vgll3 have previously been linked to puberty timing in humans and reproductive age in salmon. Killifish have short lifespans (a few months), making them suitable for aging studies.

This study provides experimental evidence in vertebrates for a genetic trade-off between early growth and later disease risk.

"What's fascinating – and slightly terrifying – is that the cancer we see in these fish isn't a random accident. It's the direct shadow of their youthful vitality."
— Itamar Harel

Implications for Human Health

Humans also possess the vgll3 gene, though its function in humans may differ. Further research might enable scientists to separate early-life benefits from late-life harms, potentially informing cancer treatments and healthy aging strategies.

Publication

The study was published in Nature Communications.